Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

5.41

Margin Of Safety %

39

Put/Call OI Ratio

0.61

EPS Next Q Diff

EPS Last/This Y

0.82

EPS This/Next Y

0.38

Price

28

Target Price

39.43

Analyst Recom

2.11

Performance Q

-32.12

Relative Volume

1.37

Beta

0.76

Ticker: OMCL




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-04-14OMCL31.580.65999.991532
2025-04-15OMCL31.320.66999.991541
2025-04-16OMCL30.920.580.671474
2025-04-17OMCL30.260.580.831478
2025-04-18OMCL30.280.580.831478
2025-04-21OMCL29.630.610.111419
2025-04-22OMCL29.910.610.501410
2025-04-23OMCL30.660.610.001428
2025-04-24OMCL31.180.6153.001434
2025-04-25OMCL30.960.668911335578999.991487
2025-04-28OMCL30.840.679012345679013.51496
2025-04-29OMCL31.410.680.041504
2025-04-30OMCL31.420.69999.991522
2025-05-01OMCL31.410.69999.991522
2025-05-02OMCL31.130.690.011523
2025-05-05OMCL30.490.650.201588
2025-05-06OMCL25.640.607.891556
2025-05-07OMCL24.650.580.811531
2025-05-08OMCL25.410.571.001582
2025-05-09OMCL25.80.590.631658
2025-05-12OMCL27.470.592.501681
2025-05-13OMCL28.020.610.201705
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-04-14OMCL31.61582.0- 1.78
2025-04-15OMCL31.35582.0- 1.78
2025-04-16OMCL30.91582.0- 1.78
2025-04-17OMCL30.28582.0- 1.78
2025-04-18OMCL30.28582.0- 1.77
2025-04-21OMCL29.66582.0- 1.77
2025-04-22OMCL29.92582.0- 1.77
2025-04-23OMCL30.69582.0- 1.77
2025-04-24OMCL31.18582.0- 1.77
2025-04-25OMCL30.96582.0- 1.77
2025-04-28OMCL30.84582.0- 1.77
2025-04-29OMCL31.40582.0- 1.77
2025-04-30OMCL31.26582.0- 1.77
2025-05-01OMCL31.38582.0- 1.77
2025-05-02OMCL31.16582.0- 1.77
2025-05-05OMCL30.49582.0- 1.77
2025-05-06OMCL25.62582.0- 1.77
2025-05-07OMCL24.63582.0- 1.77
2025-05-08OMCL25.41-18.0- 1.77
2025-05-09OMCL25.78-51.6- 1.09
2025-05-12OMCL27.46-51.6- 1.09
2025-05-13OMCL28.00-51.6- 1.09
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-04-14OMCL-0.094.144.89
2025-04-15OMCL-0.094.144.89
2025-04-16OMCL-0.094.144.89
2025-04-17OMCL-0.094.144.89
2025-04-18OMCL-0.094.144.89
2025-04-21OMCL-0.094.194.89
2025-04-22OMCL-0.094.194.89
2025-04-23OMCL-0.094.194.89
2025-04-24OMCL-0.094.194.89
2025-04-25OMCL-0.094.194.89
2025-04-28OMCL-0.093.785.30
2025-04-29OMCL-0.093.785.30
2025-04-30OMCL-0.093.785.30
2025-05-01OMCL-0.093.785.30
2025-05-02OMCL-0.093.785.30
2025-05-05OMCL-0.09-0.065.30
2025-05-06OMCL-0.09-0.065.30
2025-05-07OMCL-0.09-0.065.30
2025-05-08OMCL-0.09-0.065.30
2025-05-09OMCL-0.09-0.065.30
2025-05-12OMCL-0.09-2.655.41
2025-05-13OMCL-0.09-2.655.41
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.25

Avg. EPS Est. Next Quarter

0.23

Insider Transactions

-0.09

Institutional Transactions

-2.65

Beta

0.76

Average Sales Estimate Current Quarter

275

Average Sales Estimate Next Quarter

284

Fair Value

38.92

Quality Score

45

Growth Score

67

Sentiment Score

3

Actual DrawDown %

85.1

Max Drawdown 5-Year %

-86.6

Target Price

39.43

P/E

61.62

Forward P/E

19.5

PEG

P/S

1.15

P/B

1.04

P/Free Cash Flow

10.49

EPS

0.45

Average EPS Est. Cur. Y​

1.09

EPS Next Y. (Est.)

1.47

Target Price Estimates Raised

Target Price Estimates Lowered

1

Profit Margin

1.87

Relative Volume

1.37

Return on Equity vs Sector %

-22.7

Return on Equity vs Industry %

-14.3

EPS 1 7Days Diff

-0.7

EPS 1 30Days Diff

-0.69

EBIT Estimation

Omnicell, Inc.
Sector: Healthcare
Industry: Health Information Services
Employees: 3620
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was incorporated in 1992 and is headquartered in Fort Worth, Texas.
stock quote shares OMCL – Omnicell, Inc. Stock Price stock today
news today OMCL – Omnicell, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OMCL – Omnicell, Inc. yahoo finance google finance
stock history OMCL – Omnicell, Inc. invest stock market
stock prices OMCL premarket after hours
ticker OMCL fair value insiders trading